Experimental and Therapeutic Investigations With Certain New Hydrogenated Ergot Alkaloids in Peripheral Vascular Disorders

Abstract

Get full access to this article

View all access options for this article.

References

Rothlin, E. : Pharmacology of Natural and Dihydrogenated Alkaloids of Ergot. Bull. Schweiz. Akad. d. med. Wissensch. 2: No. 4, 1946/47.

Bircher, R. AND Cerletti, A. : Pharmakodynamische Grundlagen der Therapie von Kreislaufstörungen mit den Dihydroalkaloidendes Mutterkorns. Helvet. med. acta. 16: Suppl. 22, p. 13, 1949.

Kappert, A. , ET AL.: Untersuchungen über die Wirkungen neuer dihydrierter Mutterkornalkaloide bei peripheren Durchblutungsstörungen und Hypertonie. Helvet. med. acta. 16: Suppl. 22, p. 27, 1949 .

Kramer, D.W. : Peripheral Vascular Diseases. Diagnosis and Treatment, Philadelphia, F. A. Davis, 1948.

Allen, E.V. , Barker, N.W. , AND Hines, E.A. , JR.: Peripheral Vascular Diseases, Philadelphia , W. B. Saunders, 1946.

Bluntschli, R.J. AND Goetz, R.H. : The Effect of a New Sympathicolytic Drug (Dihydroergocornine) on the Blood Pressure with Special Reference to Hypertension . South African M. J. 21: 382 (June 14) 1947.

Goetz, R.H. : The Action of Dihydroergocornine on the Circulation. Lancet 256: 510 (March 26) 1949.